265 related articles for article (PubMed ID: 30742665)
1. Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis.
Parodis I; Ding H; Zickert A; Cosson G; Fathima M; Grönwall C; Mohan C; Gunnarsson I
PLoS One; 2019; 14(2):e0212068. PubMed ID: 30742665
[TBL] [Abstract][Full Text] [Related]
2. Plasma sMer, sAxl and GAS6 levels correlate with disease activity and severity in lupus nephritis.
Gong S; Xu Z; Liu Y; Xing L; Ma J; Yu C; Liu X; Jia X; Xie R; Sui M
Eur J Clin Invest; 2019 Mar; 49(3):e13064. PubMed ID: 30588607
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.
Parodis I; Ding H; Zickert A; Arnaud L; Larsson A; Svenungsson E; Mohan C; Gunnarsson I
Scand J Rheumatol; 2017 Jul; 46(4):263-272. PubMed ID: 27973968
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research Consortium.
Soliman SA; Haque A; Mason S; Greenbaum LA; Hicks MJ; Mohan C; Wenderfer SE
Lupus; 2021 Aug; 30(9):1394-1404. PubMed ID: 33990158
[TBL] [Abstract][Full Text] [Related]
6. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus.
Liphaus BL; Lima L; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
Clin Rheumatol; 2020 Feb; 39(2):509-514. PubMed ID: 31655933
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
[TBL] [Abstract][Full Text] [Related]
8. Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study.
Hwang J; Kim HJ; Oh JM; Ahn JK; Lee YS; Lee J; Kim YG; Huh WS; Seo J; Koh EM; Cha HS
Rheumatol Int; 2012 Jul; 32(7):1877-84. PubMed ID: 21442173
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity.
Zizzo G; Guerrieri J; Dittman LM; Merrill JT; Cohen PL
Arthritis Res Ther; 2013; 15(6):R212. PubMed ID: 24325951
[TBL] [Abstract][Full Text] [Related]
10. Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis.
Parodis I; Adamichou C; Aydin S; Gomez A; Demoulin N; Weinmann-Menke J; Houssiau FA; Tamirou F
Rheumatology (Oxford); 2020 Nov; 59(11):3424-3434. PubMed ID: 32353879
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the 2018 and 2003 International Society of Nephrology/Renal Pathology Society classification in terms of renal prognosis in patients of lupus nephritis: a retrospective cohort study.
Umeda R; Ogata S; Hara S; Takahashi K; Inaguma D; Hasegawa M; Yasuoka H; Yuzawa Y; Hayashi H; Tsuboi N
Arthritis Res Ther; 2020 Nov; 22(1):260. PubMed ID: 33148339
[TBL] [Abstract][Full Text] [Related]
12. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.
Nived O; Hallengren CS; Alm P; Jönsen A; Sturfelt G; Bengtsson AA
Scand J Rheumatol; 2013; 42(5):383-9. PubMed ID: 23829689
[TBL] [Abstract][Full Text] [Related]
13. Outcome of childhood lupus nephritis in Saudi children.
Al-Mayouf SM; AlAmeer A; Alfattani A; Alsonbul A
Saudi J Kidney Dis Transpl; 2017; 28(5):1015-1020. PubMed ID: 28937057
[TBL] [Abstract][Full Text] [Related]
14. Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.
Navarro D; Ferreira AC; Viana H; Carvalho F; Nolasco F
Acta Med Port; 2019 Oct; 32(10):635-640. PubMed ID: 31625875
[TBL] [Abstract][Full Text] [Related]
15. Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus.
Mok CC; Ding HH; Kharboutli M; Mohan C
Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1303-9. PubMed ID: 26749069
[TBL] [Abstract][Full Text] [Related]
16. Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan.
Nakano M; Kubo K; Shirota Y; Iwasaki Y; Takahashi Y; Igari T; Inaba Y; Takeshima Y; Tateishi S; Yamashita H; Miyazaki M; Sato H; Kanda H; Kaneko H; Ishii T; Fujio K; Tanaka N; Mimori A
Lupus; 2019 Aug; 28(9):1062-1073. PubMed ID: 31296139
[TBL] [Abstract][Full Text] [Related]
17. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
Chen YM; Hung WT; Liao YW; Hsu CY; Hsieh TY; Chen HH; Hsieh CW; Lin CT; Lai KL; Tang KT; Tseng CW; Huang WN; Chen YH
Lupus; 2019 Apr; 28(5):658-666. PubMed ID: 30971165
[TBL] [Abstract][Full Text] [Related]
18. Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort study.
Karlsson L; Zickert A; Svenungsson E; Schmidt-Mende J; Faustini F; Gunnarsson I
Clin Rheumatol; 2023 Nov; 42(11):2981-2986. PubMed ID: 37439924
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus.
Ekman C; Jönsen A; Sturfelt G; Bengtsson AA; Dahlbäck B
Rheumatology (Oxford); 2011 Jun; 50(6):1064-9. PubMed ID: 21278074
[TBL] [Abstract][Full Text] [Related]
20. AXL receptor tyrosine kinase is increased in patients with heart failure.
Batlle M; Recarte-Pelz P; Roig E; Castel MA; Cardona M; Farrero M; Ortiz JT; Campos B; Pulgarín MJ; Ramírez J; Pérez-Villa F; García de Frutos P
Int J Cardiol; 2014 May; 173(3):402-9. PubMed ID: 24681018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
